Xcout IntelClostraBio, Inc.
ClostraBio, Inc. is a Chicago-based biotechnology research company pioneering microbiome-based solutions, next-generation probiotics for gut health, and advanced metabolite delivery solutions for inflammatory bowel disease.
Subscribe to see ClostraBio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ClostraBio, Inc. at a glance
ClostraBio, Inc. is a biotech company headquartered in United States. It has raised at least $13.4M across the 2 funding rounds on record. Its most recent funding round raised $9.9M in September 2022. Xcout tracks 6 named people at ClostraBio, Inc., including Ritu Shah (Chief Executive Officer).
ClostraBio, Inc. leadership
- Ritu ShahChief Executive Officer
- Brett NewswangerChief Operating Officer
- Brian MeehanChief Science Officer
- Jeffrey A. HubbellCo-founder, Scientific Advisor & Board Member
- John FlavinBoard Chair
- Scott RavechSenior Strategy Advisor & Board Member
ClostraBio, Inc. funding rounds
At least $13.4M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $9.9M | — | |
| Seed | $3.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
ClostraBio, Inc. competitors
A few of ClostraBio, Inc.'s closest competitors — see the full list of competitors and alternatives →
cTRL Therapeutics is a biotechnology research company headquartered in Chicago, Illinois, United States, focused on innovative cellular science and therapeutics.
Federation Bio is a U.S. biotechnology company developing live biotherapeutic products based on defined microbial communities to treat diseases. Its work has focused on microbiome-based therapies for metabolic and other serious disorders, serving patients with conditions that may benefit from engineered microbial consortia.
Notitia Biotechnologies Co develops microbiome-focused products and programs aimed at promoting and restoring the Foundation Guild of gut bacteria for wellness and clinical applications. The company serves patients and the general public seeking to improve their gut health and overall healthspan.
Codebreaker Bioscience is a privately held bioscience platform startup founded in 2023 that develops microbiome-related solutions and is based in Chile.
The OpenBiome Foundation expands patient access to microbiome therapies and drives scientific discovery to advance human health. The organization provides resources, strategic collaborations, and investments to equip clinicians, researchers, and healthcare systems with tools for microbiome-directed treatments.
BiomeBank develops and commercializes microbiome therapeutics designed to restore gut ecological complexity and treat human diseases. The company offers regulated donor-derived therapies, such as BIOMICTRA for recurrent Clostridioides difficile infections, and is advancing a pipeline of next-generation co-cultured microbial products for conditions spanning immunology, metabolism, and oncology. It serves medical practitioners and patients by providing clinically informed gut health treatments.
Get ClostraBio, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ClostraBio, Inc. in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access